NextCure (NXTC) Accumulated Depreciation (2018 - 2025)
NextCure (NXTC) posted quarterly Accumulated Depreciation of $25.3 million for Q4 2025, up 9.46% year-over-year from $23.1 million in Q4 2024, and up 9.46% quarter-over-quarter from $23.1 million in Q4 2024.
NextCure (NXTC) Accumulated Depreciation (2018 - 2025) Analysis & Trends
NextCure's Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $25.3 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 9.46% year-over-year to $25.3 million; the TTM figure through Dec 2025 stood at $25.3 million (up 9.46% YoY), while the FY2025 annual figure was $25.3 million, up 9.46% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $25.3 million, up from $23.1 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $25.3 million in Q4 2025, with the low at $12.7 million in Q4 2021.
- The 5-year median for Accumulated Depreciation is $20.2 million (2023), against an average of $19.6 million.
- The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation surged 48.8% in 2021, then gained 9.46% in 2025.
- NextCure's Accumulated Depreciation stood at $12.7 million in 2021, then jumped by 30.56% to $16.6 million in 2022, then increased by 21.64% to $20.2 million in 2023, then gained by 14.17% to $23.1 million in 2024, then climbed by 9.46% to $25.3 million in 2025.
- Business Quant data shows NXTC's Accumulated Depreciation at $25.3 million in Q4 2025, $23.1 million in Q4 2024, and $20.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.28 Mn |
| Dec 31, 2024 | 23.10 Mn |
| Dec 31, 2023 | 20.23 Mn |
| Dec 31, 2022 | 16.63 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Dec 31, 2020 | 8.56 Mn |
| Dec 31, 2019 | 5.15 Mn |
| Sep 30, 2019 | 4.40 Mn |
| Jun 30, 2019 | 3.61 Mn |
| Mar 31, 2019 | 3.03 Mn |
| Dec 31, 2018 | 2.47 Mn |